tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market

Kazia Therapeutics (KZIA) Stock News & Sentiment

166 Followers
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
PremiumCompany Announcements
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
6d ago
Kazia Therapeutics (KZIA) has released an update. Kazia Therapeutics has announced promising results from the GBM AGILE phase II/III trial for their drug paxalisib, showing a significant improvement in overall ...Read more
Kazia Therapeutics Announces Executive Changes
PremiumCompany Announcements
Kazia Therapeutics Announces Executive Changes
22d ago
Kazia Therapeutics Granted Nasdaq Compliance Extension
PremiumCompany Announcements
Kazia Therapeutics Granted Nasdaq Compliance Extension
2M ago

News Score - Last 7 Days

Very Positive
KZIA
Sector Average
Media Buzz
This Week16 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KZIA’s Media Buzz Sentiment?
16 articles about KZIA were published this week. In an average week, 4.5 articles are published.
    What is KZIA’s weekly average amount of articles?
    In an average week, 4.5 articles about KZIA are published.
      What is KZIA’s News Sentiment?
      100% of articles about KZIA were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        KZIAKazia Therapeutics
        FARNFaron Pharmaceuticals Oy
        UTHRUnited Therapeutics
        SYABSYNLAB AG
        HAEHaemonetics
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis